| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/31/2008 | WO2008068429A3 Composition for the prevention and/or treatment of diseases associated with tnf and/or il-12 overexpression |
| 07/31/2008 | WO2008059223A3 Process for the synthesis of moxifloxacin hydrochloride |
| 07/31/2008 | WO2008059068A3 Carbonyl-substituted titanocenes |
| 07/31/2008 | WO2008057875A3 Inhibitors of hepatitis c virus |
| 07/31/2008 | WO2008036653A3 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 07/31/2008 | WO2008025847A3 Use of c7 sugars in prevention and treatment of mycoses |
| 07/31/2008 | WO2008020085A3 Use of chloro- and fluoromethyl ketone derivatives in anti-viral therapy |
| 07/31/2008 | WO2008005511A3 Novel inhibitors of hepatitis c virus replication |
| 07/31/2008 | WO2007144569A3 Antiviral astragalus extract |
| 07/31/2008 | WO2003064596A8 Desaturase genes, enzymes encoded thereby, and uses thereof |
| 07/31/2008 | US20080182981 Method and medicament for inhibiting the expression of a given gene |
| 07/31/2008 | US20080182900 Method of treatment of virus infections using shikonin compounds |
| 07/31/2008 | US20080182895 Identification and characterization of hcv replicon variants with reduced susceptibility to hcv-796, and methods related thereto |
| 07/31/2008 | US20080182885 Modified Azole Compounds As Antifungal and Antibacterial Agents |
| 07/31/2008 | US20080182883 e.g. 1-Benzyl-3-pentyl-2-[6-(1H-tetraazol-5-ylmethoxy)-2-naphthyl]-1H-indole; stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders |
| 07/31/2008 | US20080182870 PYRIDO(3,2-d)PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS |
| 07/31/2008 | US20080182863 e.g. 4-[2-(5-Chloro-2-fluoro-phenyl)-7-(2-dimethylamino-ethylamino)-pyrido-[2,3-d]pyrimidin-4-ylamino]-nicotinic acid; viricide; transforming growth factor-beta inhibitor; hepatitis C infection; fibroproliferative conditions: fibrosis, glomerulonephritis, diabetic nephropathy, and certain cancers |
| 07/31/2008 | US20080182857 Heat Shock Protein 90 inhibitors; 5-(2,4-dihydroxyphenyl)-4-(naphth-1-yl)-4H-1,2,4-triazole-3-thiol; incorrect protein folding or aggregation; hydrazonederivatives react with dimiadazole cabonyl/thiocarbonyl derivatives; hydrazines derivatives react with isocyanate or isothiocyanates; tumors, cancer |
| 07/31/2008 | US20080182855 Antibacterial Quinoline Derivatives |
| 07/31/2008 | US20080182837 New chemical compounds |
| 07/31/2008 | US20080182835 Cobalt attached/coordinated to 6 same or different ligands including a N-based ligand donor atom that is ammonia, primary amine or secondary amine, or salt; does not have free cobalt(III) coordination sites and does not hydrolyze oligonucleotides; complex may be bound to an oligonucleotide |
| 07/31/2008 | US20080182814 Beta-L-2'-deoxynucleosides for the treatment of resistant HBV strains and combination therapies |
| 07/31/2008 | US20080182790 Nucleic acid encoding protein which has autoinducer inactivation activity; increase disease resistance in plants and animals; capable of efficient inactivation of N-acyl homoserine lactone autoinducers |
| 07/31/2008 | US20080182320 Two-step immunization procedure against chlamydia infection |
| 07/31/2008 | US20080182314 Neuronal serine threonine protein kinase |
| 07/31/2008 | US20080182302 Open reading frames which encode polypeptides sufficient to direct the biosynthesis synthesis of a safracin molecule having improved properties and that could be used in the hemi-synthesis of new ecteinascidins compounds; combinatorial chemistry; antitumor agents; broad-spectrum antibiotics; bactericides |
| 07/31/2008 | US20080182292 Investigation of new membrane tubes containing F-actin and myosin of a diameter of 50-400 nm and <50+ micrometers length which span the cells; spreading, incubating and staining with a detectable microscopic stain, fluorescent dye, to obtain stained plasma membranes for 3-D cell microscopy |
| 07/31/2008 | US20080181969 polypropylene theromplastic polymer, 3-(3,5-di-tert-butyl-4-hydroxyphenyl)-propionic acid and diphenyl disulfide antioxidants, silver sulfate as antimicrobial agent; improvements in color of melt-processed thermoplastic polymer |
| 07/31/2008 | US20080181951 Treatment of humans with colloidal silver composition |
| 07/31/2008 | US20080181948 Solid pharmaceutical dosage formulations |
| 07/31/2008 | US20080181918 Immunogens; vaccines; fusion proteins |
| 07/31/2008 | US20080181915 Cd40 ligand adjuvant for respiratory syncytial virus |
| 07/31/2008 | US20080181914 an inactivated, disrupted influenza virus preparation of a hemagglutinin antigen stabilised by alpha-tocopherol succinate in the absence or at low levels of thiomersal; hemagglutinin detectable by a single radial immunoassay (SRID); mercury-free preservative; administering by any route |
| 07/31/2008 | US20080181913 Sugar immunogens |
| 07/31/2008 | US20080181910 administering a porcine circovirus type 2 (PCV2) antigen, such as recombinant baculovirus expressed ORF2 antigen to a pig; lymphadenopathy, lymphoid depletion and/or multinucleated/giant histiocytes |
| 07/31/2008 | US20080181909 Chimeric immunomodulatory compounds and methods of using the same |
| 07/31/2008 | US20080181908 Genes and proteins, and their use |
| 07/31/2008 | US20080181905 Nanoemulsion Vaccines |
| 07/31/2008 | US20080181884 administering a synergistic mixture comprising an antibody, Anidulafungin (LY303366) and amphotericin B; for drug resistanct infections; induce immunology response; diagnosis of a patient with a Coccidioidomycosis infection |
| 07/31/2008 | US20080181868 Macrocylic oximyl hepatitis c protease inhibitors |
| 07/31/2008 | US20080181866 treating hepatitis C virus infections; 2-[4-(4-Cyclopropylcarbamoyl-phenyl)-thiazol-2-ylcarbamoyl]-indole-1-carboxylic acid benzyl ester; inhibiting viral and host cell targets in the replication cycle |
| 07/31/2008 | US20080179246 Method of obtaining a natural hydroxytyrosol-rich concentrate from olive tree residues and subproducts using clean technologies |
| 07/31/2008 | CA2696603A1 Jc virus vaccine |
| 07/31/2008 | CA2676481A1 Papaya mosaic virus-based vaccines against salmonella typhi and other enterobacterial pathogens |
| 07/31/2008 | CA2676353A1 Production of rosmarinic acid from spearmint and uses thereof |
| 07/31/2008 | CA2676239A1 Self-assembling amphiphilic polymers as antiviral agents |
| 07/31/2008 | CA2676061A1 Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof |
| 07/31/2008 | CA2675934A1 Antiviral compounds |
| 07/30/2008 | EP1950302A2 Streptococcus antigens |
| 07/30/2008 | EP1950301A2 Antibody for use in Therapy |
| 07/30/2008 | EP1950224A2 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 07/30/2008 | EP1950223A2 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 07/30/2008 | EP1950221A2 Genomic sequences of exported mycobacteria polypeptides, vectors containing them and applications to the diagnosis and prevention of tuberculosis |
| 07/30/2008 | EP1950218A1 Sulfoglycolipid antigens, their process of preparation, and their use against tuberculosis |
| 07/30/2008 | EP1950199A1 Proline derivatives and use thereof as drugs |
| 07/30/2008 | EP1949914A1 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 07/30/2008 | EP1949905A1 Reovirus for the treatment of cellular proliferative disorders |
| 07/30/2008 | EP1949901A2 Inhibition of inflammation using alpha 7 receptor-binding cholinergic agonists |
| 07/30/2008 | EP1949888A1 Water-in-oil emulsions with ethylene oxide groups, compositions, and methods |
| 07/30/2008 | EP1948818A2 Use of b cell expansion agents in generating antibodies |
| 07/30/2008 | EP1948802A1 Chimeric antigen containing hepatitis c virus polypeptide and fc fragment for eliciting an immune response |
| 07/30/2008 | EP1948788A1 Method of expanding double negative t cells |
| 07/30/2008 | EP1948666A1 Hiv integrase inhibitors |
| 07/30/2008 | EP1948660A1 Tetracyclic indole derivatives as antiviral agents |
| 07/30/2008 | EP1948642A1 4-heteroarymethyl substituted phthalazinone derivatives |
| 07/30/2008 | EP1948635A1 Benzimidazole derivatives as gyrase inhibitors |
| 07/30/2008 | EP1948621A1 Hiv integrase inhibitors |
| 07/30/2008 | EP1948619A2 6-vinyl pyrimidine and pyrimidinone derivatives and the use thereof |
| 07/30/2008 | EP1948316A1 Enhancement of antitubercular activity of extracts of salicornia brachiata |
| 07/30/2008 | EP1948215A1 Inhibitors of parp activity and uses thereof |
| 07/30/2008 | EP1948204A1 System and method for the prevention and treatment of bacterial and fungal infections including urinary tract infections (uti) using a hypohalous acid compositions |
| 07/30/2008 | EP1948196A2 Use of tetraorganosilicon compounds |
| 07/30/2008 | EP1948147A2 Compositions useful for prevention and treatment of common cold and influenza-like symptoms |
| 07/30/2008 | EP1947943A2 Small molecule inhibitors of hiv-1 capsid assembly |
| 07/30/2008 | EP1565547B1 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 07/30/2008 | EP1531817B1 Glycinamide derivatives as raf-kinase inhibitors |
| 07/30/2008 | EP1480993B1 Desaturase genes, enzymes encoded thereby, and uses thereof |
| 07/30/2008 | EP1480646B1 Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident |
| 07/30/2008 | EP1423525B1 Recombinant mva capable of expressing structural hcv antigens |
| 07/30/2008 | EP1418881B1 Synergistic antimicrobial ophthalmic preparations containing chlorite and hydrogen peroxide |
| 07/30/2008 | EP1366078B1 Ige receptor antagonists |
| 07/30/2008 | EP1340086B1 Assay for directly detecting a rs virus related biological cell in a body fluid sample |
| 07/30/2008 | EP1285663B1 Protective interferon-beta against reinfection after liver transplantation |
| 07/30/2008 | EP1239876B1 Hcv vaccine compositions |
| 07/30/2008 | EP1226170B1 Human chordin and polynucleotides encoding the same |
| 07/30/2008 | EP1028118B1 Process for producing 3-cephem compounds |
| 07/30/2008 | EP1025124B1 Low-toxicity human interferon-alpha analogues |
| 07/30/2008 | EP0776209B1 Polynucleic acids and proteins from a porcine reproductive and respiratory syndrome virus and uses thereof |
| 07/30/2008 | CN101233148A Macrocyclic peptides as HCV NS3 protease inhibitors |
| 07/30/2008 | CN101233147A Macrocyclic inhibitors of hepatitis c virus |
| 07/30/2008 | CN101233141A Ascomycin crystalline forms and preparation thereof |
| 07/30/2008 | CN101233137A Macrocylic inhibitors of hepatitis c virus |
| 07/30/2008 | CN101233131A Macrocyclic inhibitors of hepatitis c virus |
| 07/30/2008 | CN101232884A Quinoline derivatives as antibacterial agents |
| 07/30/2008 | CN101232881A Bicyclic 6-alkylidene-penem beta-lactamase inhibitors and beta-lactam antibiotic combination: a broad spectrum antibiotic |
| 07/30/2008 | CN101230336A Gm-negative ehv-mutants |
| 07/30/2008 | CN101230099A Streptococcus pneumoniae proteins and nucleic acid molecules |
| 07/30/2008 | CN101230096A Peptide derived from hepatitis C virus |
| 07/30/2008 | CN101230083A Novel glycyrrhetinic acid derivatives and preparation method thereof |
| 07/30/2008 | CN101230070A Novel anti-infection cephalosporin compounds |